Aytu BioScience logo
Aytu BioScience AYTU
$ 2.67 0.75%

Quarterly report 2025-Q4
added 02-03-2026

report update icon

Aytu BioScience Operating Cycle 2011-2026 | AYTU

Annual Operating Cycle Aytu BioScience

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
360 420 188 206 225 552 325 296 398 223 382 - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
552 188 325

Quarterly Operating Cycle Aytu BioScience

2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
347 420 - 330 328 366 - 519 430 389 - 241 224 194 102 216 227 262 131 194 171 281 169 207 391 452 267 477 314 400 312 449 414 468 333 335 148 308 106 309 261 684 46.7 63.6 - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
684 46.7 300

Operating Cycle of other stocks in the Biotechnology industry

Issuer Operating Cycle Price % 24h Market Cap Country
Aeterna Zentaris Aeterna Zentaris
AEZS
115 - 5.93 % $ 314 M canadaCanada
Albireo Pharma Albireo Pharma
ALBO
40.8 - -0.23 % $ 916 M usaUSA
I-Mab I-Mab
IMAB
271 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
12.8 - - $ 40.3 B usaUSA
Aptinyx Aptinyx
APTX
46.9 - -39.0 % $ 4.57 M usaUSA
Omeros Corporation Omeros Corporation
OMER
599 $ 10.41 2.26 % $ 606 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
245 - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
32 - -1.52 % $ 24.7 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
237 $ 19.54 1.61 % $ 913 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
61.7 - - $ 7.46 M israelIsrael
AgeX Therapeutics AgeX Therapeutics
AGE
78.4 - -10.17 % $ 12.2 K usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
394 - -24.86 % $ 820 K usaUSA
Acasti Pharma Acasti Pharma
ACST
1.97 - 4.01 % $ 150 M canadaCanada
BeiGene, Ltd. BeiGene, Ltd.
BGNE
52.6 - 0.49 % $ 251 B cayman-islandsCayman-islands
bluebird bio bluebird bio
BLUE
127 - - $ 546 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
104 - - - russiaRussia
Cara Therapeutics Cara Therapeutics
CARA
52.4 - -3.03 % $ 260 M usaUSA
Advaxis Advaxis
ADXS
88.1 - -9.65 % $ 45.9 M usaUSA
Processa Pharmaceuticals Processa Pharmaceuticals
PCSA
723 $ 2.33 - $ 3.05 M usaUSA
Phathom Pharmaceuticals Phathom Pharmaceuticals
PHAT
192 $ 10.41 3.48 % $ 759 M usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
1.1 K $ 47.2 1.66 % $ 4.24 B schweizSchweiz
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCC
185 - -5.98 % $ 34.1 M usaUSA
ChemoCentryx ChemoCentryx
CCXI
3.1 - - $ 3.74 B usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
512 - - $ 2.02 B usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
436 - -4.8 % $ 255 M usaUSA
Pliant Therapeutics Pliant Therapeutics
PLRX
37.6 $ 1.31 1.95 % $ 80.4 M usaUSA
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
50 $ 4.46 3.48 % $ 855 M canadaCanada
AIkido Pharma AIkido Pharma
AIKI
17.9 - 1.93 % $ 17.4 M usaUSA